Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
MiMedx Group Inc - SIC # 3841 - SURGICAL AND MEDICAL INSTRUMENTS AND APPARATUS
Ticker
Exchange
SIC #
Website
Latest Ticker
MDXG
Nasdaq
3841
https://mimedx.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for MiMedx Group Inc
Breakeven On The Horizon For MiMedx Group, Inc. (NASDAQ:MDXG)
- May 25th, 2023 5:29 pm
Q1 2023 MiMedx Group Inc Earnings Call
- May 3rd, 2023 1:22 pm
MDXG: 1Q:22 Financial Results
- May 3rd, 2023 11:21 am
MIMEDX Announces First Quarter 2023 Operating and Financial Results
- May 2nd, 2023 8:01 pm
MIMEDX to Host First Quarter 2023 Operating and Financial Results Conference Call on May 2
- Apr 18th, 2023 12:00 pm
Investors in MiMedx Group (NASDAQ:MDXG) have unfortunately lost 57% over the last five years
- Apr 13th, 2023 12:29 pm
MIMEDX Announces Chief Financial Officer Transition
- Mar 23rd, 2023 8:01 pm
MIMEDX Comments on Recent Data Brief Published by Office of Inspector General
- Mar 16th, 2023 12:00 pm
MiMedx Group, Inc. (NASDAQ:MDXG) Q4 2022 Earnings Call Transcript
- Mar 3rd, 2023 4:17 pm
MiMedx Group Full Year 2022 Earnings: In Line With Expectations
- Mar 3rd, 2023 10:17 am
Institutional investors own a significant stake of 38% in MiMedx Group, Inc. (NASDAQ:MDXG)
- Mar 1st, 2023 4:22 pm
Q4 2022 MiMedx Group Inc Earnings Call
- Mar 1st, 2023 3:13 pm
MDXG: 2022 Financial Results
- Mar 1st, 2023 9:21 am
MIMEDX Announces Fourth Quarter and Full Year 2022 Operating and Financial Results
- Feb 28th, 2023 9:01 pm
MIMEDX to Host Fourth Quarter and Full Year 2022 Operating and Financial Results Conference Call on February 28
- Feb 15th, 2023 1:00 pm
MDXG: Navigating to New Heights: MiMedx Appoints CEO
- Jan 31st, 2023 10:38 am
MIMEDX Appoints Joseph H. Capper as Chief Executive Officer and Director
- Jan 30th, 2023 1:00 pm
MIMEDX Confirms Fourth Quarter and Full Year 2022 Net Sales Expectations, Comments on Evolving Medicare Reimbursement Landscape and Provides Corporate Updates
- Jan 9th, 2023 1:02 pm
MIMEDX Announces Commercial Launch of EPIFIX® in Japan with Exclusive Distribution Agreement with GUNZE MEDICAL LIMITED
- Jan 4th, 2023 9:01 pm
MIMEDX Appoints Ricci S. Whitlow as Chief Operating Officer
- Jan 3rd, 2023 1:00 pm
Scroll